Novavax
NVAX
225 hedge funds and large institutions have $448M invested in Novavax in 2023 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 66 increasing their positions, 54 reducing their positions, and 32 closing their positions.
41% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 32
22% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 54
6% more capital invested
Capital invested by funds: $422M → $448M (+$25.7M)
5% more funds holding
Funds holding: 215 → 225 (+10)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.32% less ownership
Funds ownership: 65.82% → 65.5% (-0.32%)
7% less call options, than puts
Call options by funds: $102M | Put options by funds: $110M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$19.9M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$11M |
| 3 |
Citigroup
New York
|
+$8.8M |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$7.99M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.82M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$12M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$8.52M |
| 3 |
Coatue Management
New York
|
-$7.72M |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$6.27M |
| 5 |
Renaissance Technologies
New York
|
-$3.26M |
NVAX Hedge Fund Activity: Q3 2023 in Review
225 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q3 2023, worth a combined $448M — up 6.1% from $422M a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new NVAX positions and 32 closed out — a net gain of 13 holders — while 66 added to existing stakes and 54 trimmed.
The largest buyer was Millennium Management, adding an estimated $19.9M. The largest seller was State Street, cutting an estimated $12M.
- 225 institutional investors held Novavax (NVAX) as of Q3 2023, up from 215 in Q2 2023.
- Funds reported $448M of Novavax stock for Q3 2023, up 6.1% quarter-over-quarter.
- 45 funds opened new Novavax positions in Q3 2023 and 32 closed out, a net change of +13 holders.
- The largest Novavax buyer in Q3 2023 was Millennium Management, an estimated $19.9M added.
- The largest Novavax seller in Q3 2023 was State Street, an estimated $12M sold.
Based on aggregated 13F filings for Q3 2023.